Vitamin D Supplementation and Improvement of PCOS Therapy and IVF Outcomes in Infertile Saudi Women
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
This randomized double-blinded-controlled clinical trial consists of two protocols as follow:
protocol 1: evaluation of the therapeutic effects of Vitamin D3 supplement when given alone
and in combination with an ovulation-inducing agent (e.g., Clomiphene citrate or Letrozole)
on ovarian functional status and hormonal and metabolic features of PCOS-Vitamin D-deficient
infertile Saudi women; and protocol 2: evaluation of the effectiveness of Vitamin D3
supplement versus placebo on the clinical pregnancy rate, fertilization implantation rate,
live birth rate, and other outcome parameters following in-vitro fertilization (IVF)
application in these PCOS-Vitamin D-deficient infertile patients.
Phase:
N/A
Details
Lead Sponsor:
Umm Al-Qura University
Treatments:
Cholecalciferol Clomiphene Enclomiphene Letrozole Vitamin D Zuclomiphene